Literature DB >> 33817891

Benefits and limitations of telegenetics: A literature review.

Anita Gorrie1, Judy Gold2, Carolyn Cameron1, Molly Krause1,3, Helen Kincaid1.   

Abstract

Telegenetics involves the use of technology (generally video conferencing) to remotely provide genetic services. A telegenetics platform is critical for those with limitations or vulnerabilities compromising their ability to attend clinic in-person, including individuals in rural areas. As the demand for remote genetics services increases, and amidst the COVID-19 pandemic with social distancing practices in place, we conducted a literature review to examine the benefits and limitations of telegenetics and explore the views of patients and health professionals utilizing telegenetics. Searches of the PubMed database identified 21 relevant primary studies for inclusion. The majority of studies found acceptability of telegenetics to be high among patients and health professionals and that telegenetics provided access to genetics services for underserved communities. The main benefits cited include cost-effectiveness and reduction in travel time for genetics services providing outreach clinics and patients who would otherwise travel long distances to access genetics. Patients appreciated the convenience of telegenetics including the reduced wait times, although a minority of patients reported their psychosocial needs were not adequately met. Eight studies compared outcomes between telegenetics and in-person services; findings suggested when comparing telegenetics patients to their in-person counterparts, telegenetics patients had a similar level of knowledge and understanding of genetics and similar psychological outcomes. Some studies reported challenges related to establishing rapport and reading and responding to verbal cues via telegenetics, while technical issues were not generally found to be a major limitation. Some service adaptations, for example, counseling strategies, may be required to successfully deliver telegenetics. Further research may be necessary to gather and examine data on how telegenetics outcomes compare to that of in-person genetic counseling and adapt services accordingly.
© 2021 National Society of Genetic Counselors.

Entities:  

Keywords:  genetics services; literature review; service delivery models; telegenetics; telehealth; telemedicine

Year:  2021        PMID: 33817891     DOI: 10.1002/jgc4.1418

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  5 in total

1.  OnkoRiskNET: a multicenter, interdisciplinary, telemedicine-based model to improve care for patients with a genetic tumor risk syndrome.

Authors:  Johanna Tecklenburg; Beate Vajen; Anke Katharina Bergmann; Brigitte Schlegelberger; Susanne Morlot; Petra Anders; Paula Memenga; Elena Link; Eva Baumann; Sarah Wölffling; Evelin Schröck
Journal:  BMC Health Serv Res       Date:  2022-06-21       Impact factor: 2.908

2.  Comparison of willingness and preference for genetic counseling via telemedicine: before vs. during the COVID-19 pandemic.

Authors:  Camille O Allison; Sandra K Prucka; Sara M Fitzgerald-Butt; Benjamin M Helm; Melissa Lah; Leah Wetherill; Rebecca E Baud
Journal:  J Community Genet       Date:  2022-07-07

3.  Where is genetic medicine headed? Exploring the perspectives of Canadian genetic professionals on future trends using the Delphi method.

Authors:  Kennedy Borle; Nicola Kopac; Nick Dragojlovic; Elisabet Rodriguez Llorian; Jan M Friedman; Alison M Elliott; Larry D Lynd
Journal:  Eur J Hum Genet       Date:  2022-01-15       Impact factor: 5.351

4.  Perceptions and care Recommendations from Previvors: Qualitative analysis of female BRCA1/2 mutation Carriers' experience with genetic testing and counseling.

Authors:  Kate E Dibble; Laura K M Donorfio; Preston A Britner; Keith M Bellizzi
Journal:  Gynecol Oncol Rep       Date:  2022-05-02

5.  Exploring Rare Disease Patient Attitudes and Beliefs regarding Genetic Testing: Implications for Person-Centered Care.

Authors:  Andrew A Dwyer; Melissa K Uveges; Samantha Dockray; Neil Smith
Journal:  J Pers Med       Date:  2022-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.